Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis.

IF 20.3 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2024-10-21 DOI:10.1136/ard-2024-226017

Aiden Haghikia, Tobias Hegelmaier, Denise Wolleschak, Martin Böttcher, Vaia Pappa, Jeremias Motte, Dominic Borie, Ralf Gold, Eugen Feist, Georg Schett, Dimitrios Mougiakakos

引用次数: 0

查看原文本刊更多论文

类风湿性关节炎和重症肌无力并存患者接受 CD19-CAR T 细胞疗法的临床疗效和自身抗体血清转换。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.